Understand the source comparison
Adamax Dosage Guide: Research Application Comparison
The following table compares dosing strategies across different research contexts, showing how protocols shift based on study objectives, experimental models, and desired endpoints. Metabolic signaling assays (in vitro) 50–100mcg/mL culture medium 200–500mcg/m
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- The following table compares dosing strategies across different research contexts, showing how protocols shift based on study objectives, experimental models, and desired endpoints.
- Metabolic signaling assays (in vitro)
- 50–100mcg/mL culture medium
- 200–500mcg/mL
- Single application per passage
- N/A. No titration in static cultures
- Optimal for isolating receptor-level effects without systemic variables; dose-response curves require at least 5 concentration points between 50mcg and 1000mcg
- Rodent metabolic models (in vivo)
- 200mcg daily (subcutaneous)
- 500–750mcg daily
- Once daily, morning administration
- 14–21 days
- Standard for preclinical obesity and insulin sensitivity studies; aligns with published protocols in peer-reviewed journals; morning timing critical for circadian alignment
- Non-human primate studies
- 300mcg daily
- 800–1000mcg daily
- Once daily
- 21–28 days
- Higher absolute doses required due to body mass scaling; primate GPCR density mirrors human tissue more closely than rodent models. Findings here have stronger translational relevance
- Tissue culture longevity studies
- 100mcg/mL
- 300–400mcg/mL
- Refresh every 48 hours
- N/A. Dose held constant
- Suitable for assessing chronic low-level exposure effects on cellular senescence markers; frequent medium changes prevent peptide degradation in culture